Editor's Picks
There is no pinned content in this Editor's Picks module.
Click here to learn more about content pinning.
-
The 2011 drought devastated the Texas wheat crop, with total production only reaching 49.4 million bushels, compared to 127.5 million bushels in 2010. Due to the drought last year, more than 900,000 acres of wheat were abandoned due to extremely poor...
-
Pharmaceutical Companies (Rx&D) is pleased to announce the appointment of Deborah M. Brown, President and Managing Director, EMD Inc. , Canada as Chair of the Board of Directors for 2012. Ms. Brown assumes the role as Chair in light of the departure of...
-
Houston-based KMG’s animal division includes branded products such as Patriot cattle ear tags and Rabon and Permectrin insecticides, which protect animals from pests. According to KMG, the animal health division had revenues for the last four quarters...
-
Babe, the CEO of Bayer Corp. USA and Bayer Material Science in Robinson, plans to retire at the end of June, according to a company announcement. Mr. Babe, 54, has been president and CEO of Bayer Corp. USA since 2008, and led the MaterialScience...
-
PITTSBURGH (AP) — Bayer Corp. USA says Chief Executive Officer Greg Babe will retire at the end of June, after 36 years with the company. The U.S. subsidiary of Bayer AG says in a statement Thursday that Babe, 54, joined the company in 1976 and held...
-
He rose from intern in 1976 at the New Martinsville, W.Va. , facility to key positions in the company, including manager of the Bayer facility in Brunsbuttel, Germany; vice president of corporate quality; and senior vice president of information services.
-
The petition asked the high court to overrule a decision that nine cases involving alleged injuries to out-of-state plaintiffs who took Bayer birth control drugs shouldn't be dismissed on forum non conveniens grounds. The Supreme Court denied the...
-
US Food and Drug Administration (FDA) is expected to decide regarding Regeneron's application seeking approval to market Eylea for another eye disorder, central retinal vein occlusion by September 23, 2012. Partner Bayer intends to seek approval for the...
-
Distinguished speakers from high level corporations are scheduled to present on the program panels, and attendees from sponsoring pharmaceutical companies including AstraZeneca, Bayer, and Boehringer Ingelheim are expected. As a result of the increased...
-
GSK medicine is the first new treatment for lupus in a half-century and has been widely adopted elsewhere. Concerns are also growing about economically strong Germany, the world's third-largest market for pharmaceuticals, where IMS logged sales of $44...
-
GSK medicine is the first new treatment for lupus in a half-century and has been widely adopted elsewhere. Concerns are also growing about economically strong Germany, the world's third-largest market for pharmaceuticals, where IMS logged sales of $44...
-
Multinational giants have a clear lead in patented products, said Zhang. Germany's Bayer AG alone has developed 81 pesticides, while BASF has 29. Most Chinese companies in the sector make "replicates of foreign products whose patents expired", Zhang said.
-
My sister had gone through the same thing, but we never talked about it until our 30s. My father didn't put me in school. I waitressed. Eventually I was able to get back to New York and signed up with a temp agency and started taking jobs wherever I...
-
Helped by exposure to the rising bank, pharmaceutical and resource sectors, the index advanced 0.9% to 5,905.70. HSBC Holdings PLC and Barclays each rose 1.2%. Drug makers rose across the board. GlaxoSmithKline PLC rose 1.6% and AstraZeneca PLC added...
-
Pharmaceuticals Inc. (WPI) recently confirmed that it has filed an abbreviated new drug application (ANDA) with the US Food and Drug Administration (FDA) to market the generic version of Bayer’s (BAYRY) oral contraceptive, Beyaz. Beyaz is indicated for...
-
BLA and have been granted a PDUFA date of September 23, and diabetic macular edema where we have two Phase III studies that are ongoing, one of which – the U.S. study – is fully enrolled. We plan on initiating shortly a Phase III study in branched...
-
The lawsuit seeks to prevent Watson from commercializing its product prior to the expiration US patent number 6,441,168. Watson Pharmaceuticals has confirmed that Watson Laboratories has filed an ANDA with FDA to market Drospirenone and Ethinyl...
-
Alexandria is well-known among the Triangle's life science companies. It owns about 840,000 square feet of lab and office space in the Triangle that it leases to companies such as Bayer AG and Eisai, as well as Duke University and UNC-Chapel Hill. It's...
-
Earlier this year, Regeneron and Bayer HealthCare initiated two Phase 3 trials of EYLEA in a third indication, diabetic macular edema (DME). The VISTA-DME U.S. trial has completed enrollment and the VIVID-DME global trial is enrolling patients. ...
About Bayer
Wikipedia
Bayer AG (German, pronounced [ˈbaɪə]) (FWB: BAY, TYO: 4863) is a German chemical and pharmaceutical company founded in Barmen, Germany in 1863. Today it is headquartered in Leverkusen, North Rhine-Westphalia, Germany. It is well-known for its original brand of aspirin. Bayer is the third largest pharmaceutical company in the world. Full Article
Related Photos
-
Reuters Pictures
Marijn Dekkers, CEO of Bayer AG smiles as he attends the annual general meeting in Cologne April 29, 2011. Bayer plans to spend a combined 15 billion euros ($22.3 billion) on research and development, plants and equipment until 2013, Dekkers said.
View Photo » -
Getty Images
COLOGNE, GERMANY - APRIL 29: General view of the Bayer AG general shareholdersâ meeting on April 29, 2011 in Cologne, Germany. The Bayer shareholder's meeting takes place at the Cologne exhibition hall on April 29, 2011 in Cologne, Germany.
View Photo » -
Getty Images
NEW YORK, NY - MARCH 22: Collector Joan Bayer (L) and daughter Morgan Bayer attend Reflections: Celebrating the Life of Clark Hulings An American Master at the Forbes Gallery on March 22, 2011 in New York City.
View Photo » -
Getty Images
Germany's Sebastian Bayer gestures after the men's long jump final during the French athletics indoor championships on March 5, 2011 at the Bercy Palais-Omnisport (POPB) in Paris.
View Photo » -
Getty Images
Germany's Sebastian Bayer reacts after the long jump event of the European athletics indoor championships on March 5, 2011 at the Bercy Palais-Omnisport (POPB) in Paris. Bayer finished first ahead of Gomis and Jensen.
View Photo » -
Reuters Pictures
Germany's Sebastian Bayer (R) celebrates after winning the gold medal in the final of the Men's long jump at the European Athletics indoor championships in Paris March 5, 2011.
View Photo » -
Reuters Pictures
Germany's Sebastian Bayer competes in the final of the Men's long jump at the European Athletics indoor championships in Paris March 5, 2011. Bayer won the Gold.
View Photo » -
Getty Images
France's Kafetien Gomis (L), Germany's Sebastian Bayer (C) and Denmark's Morten Jensen stand on the podium with their medals after winning the long jump event of the European athletics indoor championships on March 5, 2011 at the Bercy Palais-Omnisport (POPB) in Paris. Bayer finished...
View Photo » -
Getty Images
Germany's Sebastian Bayer celebrates after winning the men's long jump final during the French athletics indoor championships on March 5, 2011 at the Bercy Palais-Omnisport (POPB) in Paris. Bayer finished first ahead of Gomis and Jensen.
View Photo » -
AP Photo
Germany's Sebastian Bayer jumps to win the Long Jump men's final at the European Indoor Athletics Championships in Paris, Saturday, March 5, 2011.
View Photo » -
Getty Images
PARIS, FRANCE - MARCH 05: Gold medalist Sebastian Bayer of Germany poses with silver medalist Kafetien Gomis of France (L) and bronze medalist Morten Jensen of Denmark after the Men's Long Jump during day 2 of the 31st European Athletics Indoor Championships at the Palais Omnisports de...
View Photo » -
Getty Images
PARIS, FRANCE - MARCH 05: Sebastian Bayer of Germany celebrates winning the gold medal in the Men's Long Jump during day 2 of the 31st European Athletics Indoor Championships at the Palais Omnisports de Paris-Bercy on March 5, 2011 in Paris, France.
View Photo » -
Getty Images
Wolfgang Plischke, board member of German pharmaceutical group Bayer, is pictured during a press conference on February 28, 2011 in Leverkusen, western Germany. Bayer fell into a surprise fourth quarter loss owing to charges including a write-down on its Schering brand and costs of US...
View Photo » -
Getty Images
Marijn Dekkers (L), chairman of German pharmaceutical group Bayer, and CFO Werner Baumann pose with their company's business report prior to a press conference on February 28, 2011 in Leverkusen, western Germany. Bayer fell into a surprise fourth quarter loss owing to charges including...
View Photo » -
Getty Images
Marijn Dekkers, chairman of German pharmaceutical group Bayer, takes documents out of his bag prior to a press conference on February 28, 2011 in Leverkusen, western Germany. Bayer fell into a surprise fourth quarter loss owing to charges including a write-down on its Schering brand and...
View Photo » -
Getty Images
Marijn Dekkers, chairman of German pharmaceutical group Bayer, gives a press conference on February 28, 2011 in Leverkusen, western Germany. Bayer fell into a surprise fourth quarter loss owing to charges including a write-down on its Schering brand and costs of US legal proceedings.
View Photo » -
Reuters Pictures
Bayer Management Board Chairman Marijn Dekkers answers questions during a news conference in Leverkusen February 28, 2011. Germany's largest drugmaker issued two-year targets for adjusted core earnings on Monday that fell slightly short of analysts expectations as generic competition...
View Photo » -
AP Photo
Marijn Dekkers, CEO of the pharmaceutical giant Bayer, gestures during the annual balance news conference at the company's headquarters in Leverkusen, Germany, Monday, Feb. 28, 2011. Hefty special charges caused a fourth-quarter loss at Bayer AG, though the pharmaceutical and chemical...
View Photo » -
Reuters Pictures
Marijn Dekkers (L), CEO of Bayer AG and Manfred Schneider, Chairman of Supervisory Board arrive for the annual general meeting in Cologne April 29, 2011. Bayer plans to spend a combined 15 billion euros ($22.3 billion) on research and development, plants and equipment until 2013, its...
View Photo » -
Getty Images
COLOGNE, GERMANY - APRIL 29: Victims who are convinced their physical handicaps were caused by the pregnancy test drug Duogynon pose with a banner to Bayer shareholders at the Bayer general shareholdersâ meeting on April 29, 2011 in Cologne, Germany. The victims are seeking a court...
View Photo » -
Getty Images
COLOGNE, GERMANY - APRIL 29: Marijn Dekkers, chairman of the Bayer AG management (R) speaks to Manfred Schneider, chairman of the supervisory board (L) during the general shareholdersâ meeting on April 29, 2011 in Cologne, Germany. The Bayer shareholder's meeting takes place at the...
View Photo » -
Getty Images
COLOGNE, GERMANY - APRIL 29: Marijn Dekkers, chairman of the Bayer AG management looks on during the general shareholdersâ meeting on April 29, 2011 in Cologne, Germany. The Bayer shareholder's meeting takes place at the Cologne exhibition hall on April 29, 2011 in Cologne, Germany.
View Photo » -
Getty Images
COLOGNE, GERMANY - APRIL 29: Marijn Dekkers, chairman of the Bayer AG management (L) shake hands with Manfred Schneider, chairman of the supervisory board during the general shareholdersâ meeting on April 29, 2011 in Cologne, Germany. The Bayer shareholder's meeting takes place at the...
View Photo » -
Reuters Pictures
The logo of Germany's largest drugmaker Bayer HealthCare Pharmaceuticals is pictured on the front of its building in Berlin April 28, 2011. The German drugmaker raised its full-year sales and earnings outlook on strong demand for its pesticides, as high prices for agricultural...
View Photo » -
AP Photo
Eighteen-year old Michelle Pfleger of Hackettstown, New Jersey, died last September on her way to a college class. On May 10, 2011, her mother filed a wrongful death lawsuit against Bayer Healthcare Pharmaceutical Corporation charging that Michelle Pfleger's death was caused by a fatal...
View Photo »
Reuters Pictures
Marijn Dekkers, CEO of Bayer AG smiles as he attends the annual general meeting in Cologne April 29, 2011. Bayer plans to spend a combined 15 billion euros ($22.3 billion) on research and development, plants and equipment until 2013, Dekkers said.
View Photo »
